IMPROVEMENT IN IWQOL-LITE-DERIVED HEALTH UTILITY SCORE WITH LIRAGLUTIDE 3.0 MG VERSUS PLACEBO OVER 3 YEARS IN PREDIABETES
Abstract
Authors
R.L. Kolotkin G. Smolarz H.H. Meincke J.B. Bjorner
R.L. Kolotkin G. Smolarz H.H. Meincke J.B. Bjorner
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now